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Abstract
Background: Vernonia cinerea (L.) Less is used in folk medicine as a remedy for various diseases.
Objectives: The present study reports antioxidant and antimicrobial activities of  solvent fractions of  Vernonia cinerea.
Methods: The antioxidant properties of  solvent fractions of  V. cinerea were evaluated by determining radicals scavenging activ-
ity, total flavonoid and phenolic contents measured with the  2,2-diphenyl-1-picryl hydrazyl (DPPH) test, the aluminum chloride 
and the Folin-ciocalteau methods, respectively. Antimicrobial activities were tested against human pathogenic microorganisms 
using agar diffusion method. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of  
each active extract were determined.
Results: The ethyl acetate fraction having the IC50 value of  6.50 µg/mL demonstrated comparable DPPH radical-scavenging 
activity with standard antioxidants, gallic acid and quercetin included in the study. All fractions displayed moderate antimicrobial 
potential against the tested pathogens with the zone of  inhibition that ranged from 9.0 to 13.5 mm. The MIC (1.56 mg/mL) and 
MBC (3.13 mg/mL) indicated highest susceptibility of  Candida albicans in all fractions.
Conclusion: The results of  this study showed that the solvent fractions of  V. cinerea possess antioxidant and antimicrobial ac-
tivities, hence justifying the folkloric use of  the plant for the treatment of  various ailments in traditional medicine.
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Introduction
Medicinal plants have played a vital role in the health-
care system of  man since the dawn of  human civiliza-
tion. In spite of  tremendous development in the field of  
allopathic medicines during the 20th century, plants still 
remain one of  the major sources of  drugs in modern 
as well as in traditional system of  medicine1,2. Phenolic 
compounds are part of  the main secondary metabolites, 
present in plants and these are essential components of  
human diet. Phenolic compounds are known for their an-
tioxidant, anti-inflammatory and antimicrobial activities3. 
Flavonoids, which are the most common group of  poly-
phenolic compounds, are ubiquitous in the plant king-
dom. They possess antioxidant activity and reduce lipid 
peroxidation not only by preventing or slowing the onset 
of  cell necrosis but also by improving vascularity4.
Vernonia cinerea (L.) Less, belonging to the family As-
teraceae is an annual plant widely distributed in India, 
Bangladesh, Sri Lanka and Malay island5. Vernonia cinerea 
is one of  the species of  Vernonia found in Nigeria and 
it is known as a weed6. It is commonly known as ‘little 
ironweed’ in English, “bojure” in Yoruba and “oriwo” in 
Edo7,8. The plant is extensively used in indigenous medi-
cine in stomach aches and for cold, asthma and bronchi-
tis9. The Ayurveda Pharmacopoeia of  India recommends 
the plant for the treatment of  intermittent fever, filaria-
sis, blisters, boils and vaginal discharges. The root of  the 
plant is used traditionally for the treatment of  all types of  
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eruptive boils and the juice is used for faster healing of  
accidental wounds, filariasis and toxic viral fevers.
The seeds are used in dysuria and to treat colic in the 
form of  decoction8. Young leaves of  the plant are used 
for the treatment of  tonsillitis10. The leaf  juice extract is 
used to treat skin diseases and the leaf  extract for treating 
dysentery in children11. Besides these, the plant is used in 
smoking cessation, cough, fever, malaria, urinary calculi, 
arthritis and leprosy12,13,14,15. The plant possesses antimi-
crobial16, antibacterial17, antioxidant18, antihelmentic, anti-
inflammatory, analgesic, antipyretic17,19,20, antiflautulent, 
antispasmodic8 and antidiuretic properties21. Some of  
the phytochemical compounds that have been reported 
on the plant include: sterols, flavonoids, sesquiterpene 
lactones22 and a terpenoid, ‘leupeol acetate’ which show 
antihyperglycaemic and antiulcer properties23. Further-
more, Vernonia cinerea also possesses insect-antifeedant 
property24.
The present study was carried out to determine the total 
phenolic and flavonoid content and to evaluate the an-
tioxidant and antimicrobial activities of  the partitioned 
fractions of  Vernonia cinerea.
Materials and methods
Chemicals and reagents
All solvents and acid used in this study were purchased 
analytical grade. The quercetin and gallic acid standards 
used for total phenolic and flavonoid content were pro-
cured from Sigma-Aldrich, Germany. The other chemical 
reagents were from BDH, UK.  The absorbances were 
measured using Spcetrumlab 752S UV-VIS Spectropho-
tometer.
Plant collection and identification
The whole plant of  Vernonia cinerea was collected in July, 
2013 from the botanical garden, University of  Ibadan, 
Ibadan, Oyo State, Nigeria. Plant identification was done 
by Mr. O. A. Osiyemi at the Forest Herbarium, Ibadan 
(FHI), Nigeria, where a voucher specimen FHI 109827 
was deposited. The fresh and healthy plants were sepa-
rated from the sterile ones and packed in a polythene bag. 
Samples were transported to the laboratory and kept at 
room temperature until processing.
Preparation of  extracts
The whole plant samples of Vernonia cinerea were dried 
under shade at room temperature for seven days and 
ground into powder using an electric grinding machine. 
The sample (500 g) was extracted continuously for seven 
days at room temperature with seven liters of  methanol 
with intermittent stirring. The extract was filtered using 
Whatman filter paper no. 1 and the residue was further 
extracted with five liters of  methanol. Filtrates were com-
bined and evaporated using rotary evaporator (Heidolph, 
Laborota 4000). The crude extract (21.89 g) was parti-
tioned with n-hexane (3x), chloroform (3x) and ethyl ac-
etate (3x). Each combined solvent fraction was concen-
trated at 40°C and weighed to give n-hexane (VNH, 3.6 
g), chloroform (VCH, 1.17 g), ethyl acetate (VEF, 1.42 g) 
fractions, respectively. The residual aqueous fraction was 
7.29 g in weight. The fractions were stored at 4°C until 
needed for analysis.
Determination of  total phenolic and flavonoid con-
tent
The total phenolic content (expressed as TPC) was deter-
mined by the Folin–ciocalteau method reported in litera-
ture with slight modifications25. The standard calibration 
curve was plotted using gallic acid at the concentrations 
of  0.02–0.1 mg/mL. The assay was done by mixing 0.75 
mL of  10-fold diluted Folin–Ciocalteau reagent and 100 
µL of  each solvent extract in a test tube. The mixture was 
allowed to stand at room temperature for 5 min, after 
which 0.75 mL of  6% (w/v) sodium carbonate (Na2CO3) 
solution was added. The mixture was homogenized and 
allowed to stand at room temperature for 90 min. Mix-
ture turned blue on adding 6% (w/v) Na2CO3 solution 
indicating the presence of  phenolics. Optical density of  
the sample was measured at 725 nm in triplicates using a 
Spcetrumlab 752S UV-VIS Spectrophotometer and the 
standard curve was drawn. The total phenolic contents 
were expressed as mg gallic acid equivalent (GAE) / g 
dry weight.
Colorimetric aluminium chloride method was used for 
total flavonoid content determination26,27. Briefly, 0.5 
mL solution of  each extracts in methanol was separately 
mixed with 1.5 mL of  methanol, 0.1 mL of  10% alu-
minium chloride, 0.1 mL of  1 M potassium acetate and 
2.8 mL of  distilled water and left at room temperature 
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for 30 min. The absorbance of  the reaction mixture was 
measured at 415 nm using Spcetrumlab 752S UV-VIS 
Spectrophotometer. The calibration curve was prepared 
using quercetin solutions at 6.25 to 100 µg/mL in metha-
nol.  Determination was done in triplicates. Total flavo-
noid contents were expressed as milligrams of  quercetin 
equivalent (QE) / g dry weight.
Determination of  antioxidant activity by DPPH free 
radical scavenging assay
The 2, 2-diphenyl-1-picrylhydrazyl free radical-scavenging 
activity was determined by standard methods with slight 
modification28,29. Various concentrations (100, 80, 60, 40, 
20, 10, and 5 µg/mL) of  the solvent fractions of  V. cine-
rea were prepared in methanol. The DPPH solution was 
freshly prepared for the assay. Each extract solution (2 
mL) was mixed with 1 mL of  methanol solution contain-
ing DPPH radicals (0.2 mM). The reaction mixtures were 
prepared under dim light, shaken vigorously and main-
tained for 30 min in the dark after which the absorbance 
was measured at 517 nm using a UV-VIS Spectropho-
tometer. The absorbance of  the control was obtained by 
replacing the sample with methanol. Quercetin and gallic 
acid were used as standards. The scavenging activity was 
calculated using the formula:
Scavenging activity (%) = (A517 of  control - A517 of  
sample) / A517 of  control x100.
IC50 values (the concentration of  sample, which is re-
quired to scavenge 50% of  DPPH radicals) were deter-
mined.
Antimicrobial Susceptibility Test
The organisms used for the antimicrobial tests were ob-
tained from the Medical Microbiology Department, Col-
lege of  Medicine, University College Hospital (U.C.H.), 
Ibadan, Oyo State, Nigeria. Pure cultures of  bacteria: 
Staphylococcus aureus (UCH 7580), Escherichia coli (UCH 
6504), Klebsiella pneumonia (UCH 7545), Pseudomonas aerugi-
nosa (UCH 7450), Bacillus subtillis (UCH 8536), and Proteus 
vulgaris (UCH 7206), were maintained on Mueller-Hinton 
agar slants at 4oC, while the fungi: Candida albicans (UCH 
8128) and Aspergillus flavus (UCH 9892) were maintained 
on Sabourauds’ Dextrose Agar at 4oC.
The antibacterial activity of  the solvent fractions of  V. 
cinerea was determined by the agar diffusion method using 
the well technique proposed by the Clinical and Laborato-
ry Standards Institute30. Bacterial and fungal cells suspen-
sion with equilibrated concentration of  a 0.5 McFarland 
standard in sterile saline were used to achieve concentra-
tion of  107 CFU/mL and 106 spores/mL, respectively. 
Briefly, all samples were dissolved in dimethyl-sulfoxide 
(DMSO 10%, v/v) at 10 mg/mL. Inoculum of  the bacte-
rial and fungal strains was spread using sterile swabs into 
petri dishes with 15 mL of  Mueller-Hinton Agar (MHA) 
and Sabouraud Dextrose Agar (SDA), respectively. Ster-
ile cork borer of  6 mm diameter was used to make five 
ditches (wells) on each inoculated plate and filled with 
100 µL of  the extracts and only DMSO as negative con-
trol. The plates were incubated at 37°C and 25°C for 24 
h and 48 h, respectively. After incubation time, zone of  
inhibition was measured. The experiment was performed 
in triplicates.
Antibiotic susceptibility test was carried out on the test 
bacteria as positive control. A multi-sensitivity disc bear-
ing different antibiotics was used against each of  the 
test bacteria. Each of  these was inoculated on Mueller 
Hinton agar plates and incubated at 37°C for 24 h. The 
antibiotics were- GBMTS-NEG (Lot: NH05/P) (Abtek 
Biologicals Ltd. Liverpool L9 7AR, UK) consisting of: 
ceftazidine (30 μg), cefuroxime (30 μg), nitrofurantoin 
(300 μg), gentamicin (10 μg), cefixime (5 μg), ofloxacin 
(5 μg), augmentin (30 μg), ciprofloxacin (30 μg); and DT-
POS (Lot: JB04/P) consisting of  ceftazidine (30 μg), ce-
furoxime (30 μg), cloxacillin (5 μg), erythromycin (5 μg), 
gentamicin (10 μg), ceftriaxone (30 μg), ofloxacin (5 μg) 
and augmentin (30 μg).
Determination of  Minimum Inhibitory Concentra-
tion (MIC) and Minimum Bactericidal Concentra-
tion (MBC)
Minimum inhibitory concentration is defined as the low-
est concentration of  the antimicrobial agent that will in-
hibit the visible growth of  a microorganism after over-
night incubation31,32,33. The MIC and MBC of  V. cinerea 
solvent fractions were determined by macrodilution agar 
and broth methods31,32. In the macro dilution agar meth-
od, a two-fold serial dilution of  V. cinerea fractions was 
prepared in 10% (v/v) DMSO to achieve a decreasing 
concentration range of  100 – 0.78 mg/mL. Sterile cork 
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borer of  6 mm diameter was used to bore well in the 
pre-solidified MHA plates in triplicates that had the cell 
suspension seeded with the standardized inoculum that 
has been adjusted to 0.5 McFarland standard. The control 
well was seeded with 100 µL DMSO only without plant 
extract. All the test plates were incubated at 37°C and 
observed for growth for 24 h. The lowest concentration 
of  any fraction showing a clear zone of  inhibition was 
considered as the MIC.
In the macrodilution broth method, a two-fold serial di-
lution of  the fractions was prepared in sterile BHI broth 
to achieve a decreasing concentration of  100 – 0.78 mg/
mL. Each was seeded with 100 µL of  the standardized 
inoculum. The inoculated culture tubes were incubated at 
37°C for 18 – 24 h. A set of  tubes containing only seed-
ed broth (i.e. without plant extract) was kept as control. 
The lowest concentration that did not permit any visible 
growth when compared with control was considered as 
the MIC.
The MBC is the lowest concentration of  antimicrobial 
agent that will prevent the growth of  an organism after 
subculture on to antibiotic – free media. To determine 
MBC, a 100 µL aliquot from the tube showing MIC was 
placed on MHA antibiotic – free plate and was spread 
over the plate. After incubation at 37°C for 24 h, the 
plates were examined for growth of  bacteria to determine 
the concentration of  extract at which 99.9 % killing of  
bacterial isolates was achieved.
Statistical analysis
All experimental results were expressed as mean ± stan-
dard error of  the mean of  obtained measurements. The 
results with P < 0.05 were regarded to be statistically sig-
nificant. The IC50 values for the DPPH antioxidant activ-
ity were calculated by linear regression analysis.
Results
Total phenolics and flavonoids contents
The total phenolic content in mg gallic acid equivalent/g 
of  extract by reference to standard curve (y = 14.289x + 
0.1042, r2 = 0.9831) and flavonoid reported as mg quer-
cetin equivalent/g of  extract, by reference to standard 
curve (y = 0.0157x + 0.0451, r2 = 0.9973) for the frac-
tions are summarized in Table 1. The ethyl acetate frac-
tion gave the highest phenolic (8.17 ± 1.54 mg GAE/g) 
and flavonoid contents (5.86 ± 0.24 mg GAE/g) fol-
lowed by the chloroform fraction. The lowest phenolic 
content of  2.78 ± 0.19 mg GAE/g was obtained from 
the hexane fraction.
  Table1. Total Phenolics Content (TPC)  and Total Flavonoids Content (TFC) in 
methanolic extract and fractions of Vernonia cinerea (L.) Less 
 
Extract                            Total Phenols (mg GAE/g)                    Flavonoids (mg quercetin/g) 
VNH                                     2.78±0.19                                                 4.17±0.54 
VCH                                      4.55±1.30                                                 4.48±1.47 
VEA                                      8.17±1.54                                                 5.86±0.24 
Data are represented as Mean ± S.E.M (n=3). VNH- V. cinerea n-hexane fraction, VCH- V. 
cinerea chloroform fraction, VEA- V. cinerea ethyl acetate fraction. 
DPPH free radical scavenging activity
The results of  antioxidant activity of  the fractions de-
termined by the DPPH free radical scavenging assay are 
shown in Table 2. The dose dependent activity was in 
the order: ethyl acetate > hexane > chloroform, fractions. 
The ethyl acetate fraction exhibited 63.3% DPPH radi-
cal scavenging activity at 100 μg/mL. The 50% inhibitory 
concentrations (IC50) indicating the radical scavenging ac-
tivity of  the fractions revealed the ethyl acetate fraction 
with IC50 of  6.50 µg/mL as exhibiting the highest radical 
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scavenging activity followed by the hexane fraction with 
IC50 of  8.00 µg/mL, while the lowest activity was found 
in the chloroform fraction with IC50 value of  8.63 µg/
mL. Gallic acid and Quercetin had the IC50 values of  0.62 
and 0.53 µg/mL, respectively.
Table 2. DPPH radical scavenging activity of Vernonia cinerea solvent fractions 
 
Conc. 
 µg/mL         
                     
                     
                     
   
  
Gallic acid          Quercetin VNH                 
  
  




100 92.18 ±0.00 91.32±0.00 44.5±1.30 41.56±1.73 63.33±3.64 
80 92.17±0.14 91.06±0.13 43.67±2.66 40.23±3.44 61.24±4.26 
60 92.10±0.31 91.24±0.07 40.75±1.29 39.51±1.06 60.51±2.76 
40 92.09±0.14 91.09±0.12 36.62±1.38 37.32±1.15 19.25±3.09 
20 92.09±0.14 90.97±0.13 35.80±0.92 35.06±1.01 10.36±2.10 
10 92.05±0.12 90.81±0.05 31.31±1.92 34.89±2.00 12.31±1.04 
5 91.97±0.14 90.76±0.05 29.06±1.72 29.63±1.45 10.14±1.75 
VNH = V. cinerea n-hexane fraction, VCH = V. cinerea chloroform fraction, VEA = V. 
cinerea ethyl acetate fraction 
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Antimicrobial Activity
The antimicrobial activities of  the fractions of  V. cinerea 
against clinical isolates of  human pathogenic bacteria and 
fungi are shown in Figure 1. 
Figure 1. Plates showing zone of inhibition of Vernonia cinerea fractions. 1- VCME 
(V. cinerea crude methanol), 2- VNH (V. cinerea n-hexane fraction), 
3- VCH (V. cinerea chloroform fraction), 4- VEA (V. cinerea ethyl acetate fraction)
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In the present study, six bacteria and two fungi were ex-
amined. The fractions exhibited differential effects on the 
test organisms. The maximum antimicrobial activity was 
observed with the ethyl acetate fraction followed by chlo-
roform fraction with the zone of  inhibition of  13.5 and 
12.8 mm against Escherichia coli, Pseudomonas aeruginosa and 
Bacillus subtilis, respectively. Aspergillus flavus was resistant 
to all the fractions (Table 3). 
 
Table 3. Antimicrobial activities of Vernonia cinerea solvent fractions  
against tested microorganisms. 
 
  Zone of inhibition (mm) 
Organisms Gram positive bacteria        Gram negative bacteria Fungi 










VNH 10±0.76       - 11.0±0.57 11.8±1.83 9.6±0.44 10.5±0.50 10.2±0.44  - 
VCH 10±0.28 12.6±1.36 12.0±0.50 11.7±0.72 12.8±072 12.0±0.28 10.2±0.67  - 
VEA 10.2±0.44 13.0±0.76 13.5±2.02 12.8±0.44 12.7±0.72 12.8±1.09 10.2±0.16  - 
DMSO        -       -        -       -       -        -       -  - 
  
VCME- Vernonia cinerea crude methanolic extract, VNH- V. cinerea n-Hexane fraction, VCH- V. 
cinerea chloroform fraction, VEA- V. cinerea Ethyl acetate fraction. 
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The solvent used for control (DMSO) did not show any 
activity. The antibiotic resistant pattern of  the test bacte-
ria and the antifungal susceptibility pattern to fluconazole 
(10 mg/mL) are presented in Tables 4 and 5, respectively. 
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Table 5. Antifungal Susceptibility pattern to Fluconazole (10 mg/mL) 
 
Fungi                                                      Susceptibility pattern 
Candida albican                                               Susceptible 
Aspergillus  flavus                                            Resistant 
 
Table 5. Antifungal Susceptibility pattern to Fluconazole (10 mg/mL) 
 
Fungi                                                      Susceptibility pattern 
Candida albican                                               Susceptible 
Aspergillus  flavus                                            Resistant 
 
Table 
To compare the sensitivity of  the bacterial strains to the 
fractions, each active fraction was used to determine the 
MIC and MBC. The MIC and MBC indicated highest 
susceptibility of  Candida albicans in all extracts with MIC 
value of  1.56 mg/mL and MBC value of  3.13 mg/mL 
(Table 6).
Table 4. Antibiotic Resistant Pattern of the Test Bacteria 
 
Bacteria Antibiotics Susceptibility Antibiotics Resistance 
Gram positive 
  S. 



















AUG, CAZ, CRX, CTR, 
CXC 
AUG, CAZ, CRX, CTR, 
CXC, ERY 
  
 CAZ,  AUG,CIP 
CRX, GEN, OFL, CPR 
CAZ, CRX, AUG. 
CRX, GEN,OFL,CPR 
 
Keys: OFL- Ofloxacin, GEN- Gentamicin, ERY- Erythromycin, CPR- Ciprofloxacin, NIT- Nitrofurantoin, CAZ- 
Ceftazidine, CRX- Cefuroxime, AUG- Augmentin, CTR- Ceftriaxone, CXC- Cloxacillin. 
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Table 6. Minimum inhibitory and bactericidal concentration (mg/mL) 
of methanolic extract and solvent fractions of Vernonia cinerea (L.) Less. 
 
Organisms VNH VCH VEA 































K. pneumoniae 3.13 6.25 3.13 6.25 1.56 3.13 
P. aeruginosa 3.13 6.25 3.13 6.25 6.25 12.5 















A.flavus ND ND ND ND ND ND 
 VNH- V. cinerea n-Hexane fraction, VCH- V. cinerea chloroform fraction, VEA- V. 
cinerea Ethyl acetate fraction, MIC- Minimum Inhibitory Concentration, MBC- Minimum 
Bactericidal Concentration, ND- Not determined.  
Table 6. Minimum inhibitory and bactericidal concentration (mg/mL)of methanolic 
extract and solvent fractions of Vernonia cinerea (L.) Less.
Discussion
This study provides information on the total phenolic 
and flavonoid contents of  V. cinerea in relation to the 
antioxidant and antimicrobial activities demonstrated 
by solvent fractions of  V. cinerea, which is an important 
medicinal plant. Antioxidants are important in prevent-
ing human diseases. Sources of  antioxidants are generally 
plant phenolics that can be found in all parts of  plant. 
Plant-derived phenolics such as flavonoids are of  great 
importance because they exhibit antioxidant properties 
due to their high redox potential34. Phenolics exhibit a 
considerable free radical scavenging (antioxidant) activity, 
which is determined by their reactivity as hydrogen-or-
electron donating agents. The DPPH free radical scav-
enging test in this study was conducted to evaluate the 
solvent fractions of  V. cinerea for antioxidant activity. The 
total phenolic and flavonoid contents were also deter-
mined. The results indicate that the solvent fractions of  
the whole plant extract of  V. cinerea exhibited a potential 
free radical scavenging activity. In line with the reports 
from other studies35, the ethyl acetate, a medium polar 
solvent was observed to be more effective in the extrac-
tion of  antioxidant substances from V. cinerea plant. Pre-
vious studies have reported the use of  methanol, ethanol, 
acetone, propanol, ethylacetate and dimethylformamide 
for the extraction of  phenols from fresh produce36. The 
recovery of  polyphenols from plant materials is influ-
enced by their solubility in the extraction solvent, the type 
of  solvent, the degree of  polymerization of  phenols, the 
interaction of  phenols with other plant constituents and 
the formation of  insoluble complexes37. The differences 
in the polarity of  antioxidants have been reported to be 
capable of  explaining differences in extraction yield and 
antioxidant activities, which in effect play a key role in 
increasing phenolic solubility that, may affect the anti-
oxidant activity38.  The present study demonstrated direct 
relationship between the TPC and TFC and antioxidant 
activity. Most studies have reported correlation between 
the total phenolics and antioxidant activity39, our results 
on the antioxidant activity of  V. cinerea also indicate such 
correlation. Although there are some literature reports on 
findings that suggest little or no correlation between phe-
nolic content and antioxidant activity2,40,41,42,43, the present 
study shows good correlation between both flavonoid 
and phenolic contents and antioxidant activity.
The agar diffusion methods used in this study to test an-
timicrobial activity of  the plant extracts have been widely 
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reported in literature44,45. All test organisms expressed 
various resistant pattern when tested against known com-
mercially available antibiotics. The fractions showed anti-
microbial activity against clinical isolates of  microorgan-
isms comprising of  six bacteria and a Candiada species. 
The antibacterial and antifungal activities of  the whole 
plant of  V. cinerea in the study showed that the plant is a 
broad spectrum antimicrobial agent since it inhibited the 
growth of  disease-causing Gram-positive bacteria (S. au-
reus, B. subtilis) and Gram-negative bacteria (E. coli, K. pneu-
monia, P. aeruginosa, P. vulgaris) as well as C. albicans.  How-
ever, A. niger was resistant to the extracts. Other workers 
had reported a similar finding, reporting that fungi are 
more resistant to plant extracts than bacteria46, 47,48. The 
resistance exhibited by A. niger to the tested fractions 
could be due to the presence of  more complex cell wall 
in fungi. This could also be because of  the ability of  fungi 
to produce extracellular enzymes that help in degrading 
and metabolizing substrates such that the extract acts as 
a source of  food to the fungi rather than inhibiting their 
growth49. The results confirmed that the non-polar and 
medium polar solvent fractions of  V. cinerea are potential 
sources of  antimicrobial agents. However, in line with the 
results on the antioxidant activity, the ethyl acetate frac-
tion showed better antimicrobial activity.  The results of  
our study showed that there was a disparity between the 
fractions and standard antibiotics as the former inhibited 
the growth of  organisms which some of  the standard an-
tibiotics failed to inhibit. The disparity may be due to the 
mixtures of  bioactive compounds present in the fractions 
of  V. cinerea compared to the pure compound contained 
in the standard antibiotics used in the study50. There were 
substantial differences between the MIC and MBC values 
of  various fractions. These results demonstrated that the 
VNH, VCH and VEA fractions obtained from the whole 
plant possess a high antimicrobial activity. The most sus-
ceptible bacteria were B. subtilis and E. coli.
Conclusion
The present study shows that the solvent fractions of  
Vernonia cinerea possess antimicrobial activities against 
most of  the human pathogenic bacteria tested. The most 
susceptible organisms were Bacillus subtilis, Escherichia coli 
and Pseudomonas aeruginosa. The fractions also demonstrat-
ed antioxidant activity which correlated with the amount 
of  total phenolic and total flavonoid contents that were 
obtained in the plant. The ethyl acetate fraction demon-
strated the highest activity, thus could be explored as a 
candidate for future search for antimicrobial agents for 
the cure and management of  different ailments based on 
further studies.
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